We've found
11,964 Cardiology
clinical trials
Heart Failure Clinical Trial
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Heart Failure; With Decompensation Clinical Trial
Heart Sounds Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure; With Decompensation Clinical Trial
Heart Sounds Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Idiopathic Dilated Cardiomyopathy Clinical Trial
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia (PSVT) Clinical Trial
The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
FAST Therapy Trial of Fetal Tachyarrhythmia
Status: Enrolling,
Phase
III
Updated: 12/14/2017
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
FAST Therapy Trial of Fetal Tachyarrhythmia
Status: Enrolling,
Phase
III
Updated: 12/14/2017
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Myocardial Ischemia and Transfusion
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Myocardial Ischemia and Transfusion
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases Clinical Trial
PRISM-GENOMICS-Smoking Cessation for Patients With Coronary Artery Disease Undergoing Cardiac Catheterization or Having a Heart Attack at Barnes Hospital in St. Louis Mo
Status: Enrolling
Updated: 1/2/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
ACCESS to the Cardiac Cath Lab in Patients Without STEMI Resuscitated From Out-of-hospital VT/VF Cardiac Arrest
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ventricular Tachycardia Clinical Trial
Tachy Prediction Download Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Aneurysm, Abdominal Clinical Trial
Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiac Disease Clinical Trial
Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiac Disease Clinical Trial
Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Hemodynamic-GUIDEd Management of Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Hemodynamic-GUIDEd Management of Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of ARRY-371797 in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
PULsecath mechanicaL Support Evaluation
Status: Enrolling
Updated: 2/8/2018
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Non-ST Elevation Myocardial Infarction (NSTEMI) Clinical Trial
Comparison of Pharmacodynamic Effects of Tirofiban vs. Cangrelor in N-STEMI Patients Undergoing Percutaneous Coronary Intervention
Status: Enrolling
Updated: 2/9/2018
Click here to add this to my saved trials
Single Ventricle Heart Disease Clinical Trial
Evaluation of Fontan-Associated Liver Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Post-Infarction Ventricular Septal Defect Clinical Trial
The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study
Status: Enrolling,
Phase
Updated: 5/1/2018
Click here to add this to my saved trials
Aortic Valve Stenosis Clinical Trial
A pragmatiC sTrategy to Promote actIVity and Enhance Quality of Life AFTER Transcatheter Aortic Valve Replacement
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
11,964 Cardiology
clinical trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Heart Failure; With Decompensation Clinical Trial
Updated: 12/31/1969
Heart Sounds Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure; With Decompensation Clinical Trial
Updated: 12/31/1969
Heart Sounds Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Updated: 12/31/1969
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Updated: 12/31/1969
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Updated: 12/31/1969
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Idiopathic Dilated Cardiomyopathy Clinical Trial
Updated: 12/31/1969
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia (PSVT) Clinical Trial
Updated: 12/31/1969
The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/14/2017
FAST Therapy Trial of Fetal Tachyarrhythmia
Status: Enrolling,
Phase
III
Updated: 12/14/2017
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/14/2017
FAST Therapy Trial of Fetal Tachyarrhythmia
Status: Enrolling,
Phase
III
Updated: 12/14/2017
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
Updated: 5/2/2018
3T MRI CIED Post-Approval Study
Status: Enrolling,
Phase
Updated: 5/2/2018
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
Updated: 12/31/1969
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
Updated: 12/31/1969
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
Updated: 12/31/1969
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
Updated: 12/31/1969
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
Updated: 12/31/1969
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Myocardial Ischemia and Transfusion
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Myocardial Ischemia and Transfusion
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 1/2/2018
PRISM-GENOMICS-Smoking Cessation for Patients With Coronary Artery Disease Undergoing Cardiac Catheterization or Having a Heart Attack at Barnes Hospital in St. Louis Mo
Status: Enrolling
Updated: 1/2/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
ACCESS to the Cardiac Cath Lab in Patients Without STEMI Resuscitated From Out-of-hospital VT/VF Cardiac Arrest
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ventricular Tachycardia Clinical Trial
Updated: 12/31/1969
Tachy Prediction Download Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Aneurysm, Abdominal Clinical Trial
Updated: 12/31/1969
Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiac Disease Clinical Trial
Updated: 12/31/1969
Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiac Disease Clinical Trial
Updated: 12/31/1969
Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Hemodynamic-GUIDEd Management of Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Hemodynamic-GUIDEd Management of Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of ARRY-371797 in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 2/8/2018
PULsecath mechanicaL Support Evaluation
Status: Enrolling
Updated: 2/8/2018
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Updated: 12/31/1969
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Updated: 12/31/1969
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Updated: 12/31/1969
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Updated: 12/31/1969
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Non-ST Elevation Myocardial Infarction (NSTEMI) Clinical Trial
Updated: 2/9/2018
Comparison of Pharmacodynamic Effects of Tirofiban vs. Cangrelor in N-STEMI Patients Undergoing Percutaneous Coronary Intervention
Status: Enrolling
Updated: 2/9/2018
Click here to add this to my saved trials
Single Ventricle Heart Disease Clinical Trial
Updated: 12/31/1969
Evaluation of Fontan-Associated Liver Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Post-Infarction Ventricular Septal Defect Clinical Trial
Updated: 5/1/2018
The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study
Status: Enrolling,
Phase
Updated: 5/1/2018
Click here to add this to my saved trials
Aortic Valve Stenosis Clinical Trial
Updated: 12/31/1969
A pragmatiC sTrategy to Promote actIVity and Enhance Quality of Life AFTER Transcatheter Aortic Valve Replacement
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Updated: 12/31/1969
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Updated: 12/31/1969
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Updated: 12/31/1969
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Updated: 12/31/1969
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Updated: 12/31/1969
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Updated: 12/31/1969
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Updated: 12/31/1969
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Updated: 12/31/1969
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Updated: 12/31/1969
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Updated: 12/31/1969
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Updated: 12/31/1969
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Updated: 12/31/1969
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Updated: 12/31/1969
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Updated: 12/31/1969
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials